Catalyst Wire Dossier Catalyst Wire Dossier

Pianzumab

pianzumab
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pianzumab, covering 2023-09-21 to 2024-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma [Phase 2]

See pricing